Interatrial Shunt to Go Before FDA Panel for Heart Failure Indication

By News Health
1 hour Ago

(MedPage Today) — FDA advisors on Wednesday will deliberate on whether shunt therapy still has a narrow path forward in heart failure after a disappointing pivotal trial.
In its premarket approval application for the Ventura Interatrial Shunt…

Source link : https://www.medpagetoday.com/cardiology/chf/118788

Author :

Publish date : 2025-12-02 17:41:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Cardiologist Heads New ACIP; Distal Access Catheter Recall; Another Lipid Marker?

Delaying Hep B Vaccine in Infants Carries Significant Risks, Report Warns

Join the Lifeline Chorus and Help Fight AMR

Is Your Patient Taking Herbs and Vitamins? You Won't Know Unless You Ask.

Black hole entropy hints at a surprising truth about our universe

Congo Declares Its Latest Ebola Outbreak Over, After 43 Deaths